Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Designed for high tumor penetration and long residence time, Aktis Oncology’s molecules will quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing side effects of treatment. This approach would enable clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. To learn more about Aktis Oncology, visit www.aktisoncology.com [http://www.aktisoncology.com]. The Senior Scientist in the Translational Biology group will work cross-functionally to support translational biology initiatives across the Aktis portfolio and advance the development of novel therapies to treat targeted patient populations within multiple oncology indications. The candidate will independently apply and develop cutting edge tools and methodologies to enable the advancement of company objectives with a focus clinical biomarker activities and reverse translation. As a member of the Translational Biology group within the broader Biology functional area, the candidate will work internally and with CROs to execute on the biomarker strategy and troubleshoot related challenges to advance programs through the clinic.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree